Danaher

Abbott, Cepheid, BD, Roche, Others Nab FDA 510(k) Clearances in May

In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More

Danaher Q1 Revenues Rise 12 Percent

In Brief This Week: Labcorp, QuantuMDx, LumiraDx, Danaher, Thermo Fisher Scientific, and More

Danaher Q4 Revenues Rise 21 Percent

JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More

Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results

In Brief This Week: Roche, Veracyte, Hologic, Danaher, Chembio Diagnostics, Natera, and More

Danaher Prices $1B Offering of Senior Notes

Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates

In Brief This Week: Roche, Myriad Genetics, Danaher, and More

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business

Danaher Q2 Revenues Rise 37 Percent, Driven by Life Sciences and Diagnostics Businesses

In Brief This Week: Quest Diagnostics, Ginkgo Bioworks, Novacyt, Danaher, and More

Danaher Q1 Revenues Up 58 Percent

Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance

In Brief This Week: Danaher, Guardant Health, Invitae, Yourgene Health, and More

Barclays Initiates Coverage of Danaher, Ortho, and Thermo Fisher With Overweight Ratings

In Brief This Week: Thermo Fisher, BioReference Laboratories, Hologic, Invitae, Danaher, and More